We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Blood as a Submucosal Cushion During Endoscopic Polypectomy and Mucosal Resection

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00583466
First Posted: December 31, 2007
Last Update Posted: September 13, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Johns Hopkins University
  Purpose
For removal of large flat lesions of the gastro-intestinal tract injection of a solution under the lesion creates a "safety" cushion and protects from damage to the gastrointestinal tract wall. Various solutions are currently used, but some of them are easy to inject but quickly dissipate (normal saline),other solutions are more longer lasting (hydroxypropyl methylcellulose, hyaluronic acid, etc) but are very difficult to inject and can be expensive and not always available. The investigators performed previously animal experiments which demonstrated that blood is easy to inject and creates a protective cushion which lasts longer than other fluids which are currently used for protective cushion creation.

Condition Intervention Phase
Large Polyps in the Gastrointestinal Tract Drug: Autologous blood injection Drug: Normal saline Drug: HPMC Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Evaluation of Blood as a Submucosal Cushion During Endoscopic Polypectomy and Mucosal Resection

Further study details as provided by Johns Hopkins University:

Primary Outcome Measures:
  • Duration of the Submucosal Cushion [ Time Frame: Immediately after the procedure, Up to 5 minutes ]

Enrollment: 18
Actual Study Start Date: May 2007
Study Completion Date: May 2008
Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1 Normal saline arm
Polypectomy with normal saline injected for submucosal cushion creation
Drug: Normal saline
Normal saline will be injected under the lesion to create submucosal cushion
Active Comparator: 2 HPMC arm
Polypectomy after injection of hydroxypropyl methylcellulose (HPMC) to create submucosal cushion
Drug: HPMC
Hydroxypropyl methylcellulose (HPMC) will be injected under the lesion to create submucosal cushion
Experimental: 3 Blood arm
Polypectomy after injection of autologous blood
Drug: Autologous blood injection
Autologous blood will be drawn from the patient and then reinjected under the lesion to create a safety cushion

Detailed Description:
For removal of large flat lesions of the gastro-intestinal tract injection of a solution under the lesion creates a "safety" cushion and protects from damage to the gastrointestinal tract wall. Various solutions are currently used, but some of them are easy to inject but quickly dissipate (normal saline),other solutions are more longer lasting (hydroxypropyl methylcellulose, hyaluronic acid, etc) but are very difficult to inject and can be expensive and not always available. The investigators decided to use blood drawn from the patient for injection under the lesion. The investigators performed previously animal experiments which demonstrated that blood is easy to inject and creates a protective cushion which lasts longer than other fluids which are currently used for protective cushion creation. Blood can also have local hemostatic action preventing from bleeding during polypectomy.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Polyps equal or larger than 1 cm

Exclusion Criteria:

  • Coagulopathy
  • Inability to sign informed consent
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00583466


Locations
United States, Maryland
Johns Hopkins Hospital
Baltimore, Maryland, United States, 21205
Sponsors and Collaborators
Johns Hopkins University
Investigators
Principal Investigator: Sergey V. Kantsevoy, M.D., Ph.D. Johns Hopkins University
  More Information

Publications:
Responsible Party: Johns Hopkins University
ClinicalTrials.gov Identifier: NCT00583466     History of Changes
Other Study ID Numbers: NA_00008376
First Submitted: December 20, 2007
First Posted: December 31, 2007
Results First Submitted: August 11, 2017
Results First Posted: September 13, 2017
Last Update Posted: September 13, 2017
Last Verified: September 2017

Keywords provided by Johns Hopkins University:
submucosal cushion
polypectomy
endoscopic mucosal resection